Showing posts with label Irish patents. Show all posts
Showing posts with label Irish patents. Show all posts

Tuesday, February 7, 2017

7/2/17: There's Zero Growth in Irish Patentable Innovation & Research Outputs


In a recent post on Irish patents filings and applications with the EPO, I showed that:

  1. Irish R&D and innovation performance - as reflected by patents data - is hardly impressive, with the country ranking 14th in the sample of 50 countries as an origin for EPO Applications;
  2. There has been no material improvement in Irish standing in the data in recent years, compared to trends.
Some of the readers have taken me to task on the second point, despite the fact that my evidence (based on EPO data) shows no gains in Irish patenting activities with the EPO in terms of both applications and filings, and in comparative terms as a share of both in the total number of EPO applications and filings. 

So I took a different exercise, plotting a relationship between average levels of filings and applications (combined) across 2006-2008 period against the same for 2014-2015 data. 

Not surprisingly, Ireland comes smack in the middle of the distribution and right on the regression line, implying that:
  1. Ireland's patenting performance is to the upper range of the overall distribution of 50 countries, but it is at the bottom of this sub-group of top performing countries. In fact, Ireland's position is statistically indistinguishable from 'mediocre' or 'average' group of countries. 
  2. Ireland shows only tiny growth in applications between 2006-2008 period into 2014-2015 period (see Ireland's point position just slightly above 45 degree line), which is statistically indifferent from zero growth.
  3. Once we control for the factors that drive global trend in patents (blue regression line), Ireland shows no statistically identifiable growth (Ireland's point is bang on the regression line).
Yes, patents are not the only measure of innovation and R&D, but, being the core part of STEM-focused research, they are the main measure of innovation and R&D, because patents data omits only one form of innovation - that linked to software. Now, software innovation is important, and Ireland may or may not be doing well in this sub-sector, but STEM research is based not on software innovations, but on 'hard' patents. And Ireland does not brand itself as 'Software-only Innovation Hub'. In fact, Ireland spends (as a State and economy) more on STEM innovation than on software innovation, so the key focus on Irish policies is, once again, measurable via patents.

Until we get 2016 data to update the above analysis, I rest this topic discussion.

Sunday, February 5, 2017

5/2/17: European Patents and Ireland's 'Knowledge Economy' Myths

Irish policymakers are keen on promoting Ireland as a technology and R&D centre of excellence, often claiming the country is a ‘Knowledge Economy’, a ‘Data Island’, a ‘Europe’s Tech Capital’ and so on. While catchy, these tag lines are far from reality, and, in fact, represent an empirically dubious proposition. 

To establish this claim, consider the European Patent Office data on patent filings and approvals, with the latest data set covering the period of 2006-2015. 

As chart below clearly shows, Ireland is far from being a significant source of patent filing in Europe, despite the fact that many patents from Ireland are filed by the U.S. and other multinationals, including a score of foreign companies that choose to tax-invert into Ireland. The EPO data, in fact, fails to control for this distortion. Still, even with those companies filings counted as ‘Irish’ by origin, Ireland ranks 14th in a key metric of the rate of European Patent Applications per million of inhabitants. 


Worse, Irish rate of patent applications (119 per 1 million of inhabitants) is below the mean for the sub-sample of European states (including EU28 states and other countries within the EEA). Statistically, Irish rate of patent applications per inhabitant is not distinguishable from the rates filed by Italy and Slovenia, and is well below the rate recorded for France, Belgium, Austria, Germany, Denmark, Finland, Sweden and the Netherlands. Irish numbers are also statistically indistinguishable from the global average - the average that includes non-European states’ filings. It is worth noting that the data set includes other countries, that similar to Ireland serve as major tax optimnization locations for R&D and IP, e.g. Luxembourg and the Netherlands. However, even controlling for these states, Irish data does not shine beyond being average.

In absolute terms, Irish patent filings and applications with the EPO have trended up in 2006-2010 period, but have since flat-lined (on trend) for filings and declined (on trend) for applications. 


In addition to the chart above, combined filings and applications for EPO patents by Irish-origination stood at 1,325 in 2015, down on 1,364 in 2014 and down on 1,356 average for 2008-2011 period. While data can be interpreted in a number of ways, there is clearly no indication of an improving trend in either filings or applications over the recent years. This comes on foot of aggressive acceleration in tax inversions into Ireland in previous years - an acceleration that brought into Ireland a range of large R&D-intensive companies.

Consistent with the above, Ireland’s share of all European Patent Office filings and applications has declined, on trend, in recent years, as evidenced by data presented in the chart below:


As the chart above shows, Ireland accounts of just 0.266% of all EPO patent filings and 0.364% of all EPO patent applications. Separately reported data for patents approvals shows Irish share of all patents granted by EPO to be just 0.395%. The number is laughably negligible by Europe-wide standards and is massively out of line with Irish share of European GDP. However, these numbers are consistent with the simple fact, also highlighted by EPO data, that Ireland fails to register in the top tier of generators of patents in any of the sectors tracked by EPO. 

In summary, Ireland is far from being a powerhouse for R&D and knowledge economy activities as measured by a key research output measured by European authorities. 


Saturday, March 21, 2015

21/3/15: Irish patents filings Q4 2014


Latest data on Irish patents, courtesy of NewMorningIP.com: chart below shows a decline in total patents filings in Q4 2014 compared to Q3 2014 with Q4 2014 patents counts at 699 down from Q3 2014 count of 786. Of these, Irish invention patents were down to 321 in Q4 2014 from 331 in Q3 2014, but up on 236 a year ago. In Q4 2014, Irish inventors accounted for 45.9% of total Irish patents filed, with Irish enterprises and individuals filing only 247 patents - the lowest for any quarter since Q1 2014, but ahead of the disastrously poor performance in Q4 2013 (188 Irish enterprises & individuals patents). Irish academia produced 74 patents in Q4 2014, the highest reading since Q3 2013, but still accounting for only 10.6% of total patents filed in Ireland.

Chart to illustrate:

Wednesday, November 19, 2014

19/11/2014: Irish Patents Filings: Q3 2014


As a taster for my Friday presentation at the ICA, here's a slide from my deck on Ireland and our challenges and opportunities forward:


Note: data plotted is via @newmorningip .

And here is monthly data:


One major point to be made on the above data: Irish patent filings are still falling below 50% of all filings, while Irish acedemic filings are still running at around 8% of the total. The gap between foreign and domestic filings has fallen to 73:100 in Q3 2014 from 82:100 in Q2 2014.

Monday, February 10, 2014

10/2/2014: Data shows Irish R&D policy is not exactly producing...


Today, Grant Thornton published their review of the Irish R&D Tax Credits policy, available here: http://www.grantthornton.ie/db/Attachments/Review-of-RandD-tax-credit-regime.pdf?utm_content=buffer1e77c&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer

Top level conclusions:

  • "60% of the companies that responded to the survey were indigenous Irish companies with 40% multinationals"
  • "35% of companies conducting R&D activities engaged in joint research projects with other parties in 2011"
  • "with 19.5% being activities with higher education or institutes within Ireland and 8% outside Ireland"
  • "70% of claims are by companies with less than 50 employees"
  • "large companies with employees of more than 250 employees account for 10% of claims made. However they account for 45% of claims on a monetary basis"

"The credit is a largely positive scheme with real value being added to the economy from it."

My view: too much of subsidy to MNCs, too little evidence the scheme is not being used by SMEs to fund activity that would have been funded anyway and too little evidence the scheme is being used to fund genuine R&D rather than business development.

But aside from this, there is little evidence that funding is yielding any serious uptick in intellectual property generation. Here's the latest data from the NewMorningIP on patents filings in Ireland.


Based on quarterly aggregates, in Q4 2013, total number of Irish academic patents hit the lowest reading of 48 and the goal number of filed patents match this performance at 593. Irish inventions overall sunk to the lowest level of 236 (previous low was 252 for Q3 2012, imputed on incomplete data). Patents applications by non-academic filers stood at 188 - the lowest level in data series.

Overall, in 2013, there were 2561 patents applications, of which Irish total filings amounted to 1072 (41.9%) and of which Irish non-academic patents applications were just 860 (33.6%). This is hardly stellar and cannot be deemed sustainable for the economy that is allegedly based on innovation. It also makes clear that current system of R&D incentives and supports, including tax credit, is not working.

Wednesday, December 11, 2013

11/12/2013: Irish Patenting Activity: November 2013

Reading Pictet's latest monthly, covering the topic of Swiss competitiveness... it is awesome - with interviews from academics, watchmakers, artists, museums directors, company that makes engines for Mars rovers, biotech giant, and so on. And it reminded me to update the data set on Irish patenting activity from NewMorningIP for November.

Here are the results:


Monthly data shows that November 2013 patenting activity in Ireland fell to its third lowest level since the records maintained by NewMorningIP started in August 2012. At 183 patents filed, November 2013 is down on 197 a year ago. So far, Q4 2013 results are running at the lowest level for all quarterly results.

It is worth noting that the data can be throwing seasonal variation. We can't tell due to short nature of series.

Not spectacular numbers at any rate. Big overseas inventions fall-off to 100 in November, the third lowest month on record. Irish inventions are down also.

On annual basis, 2013 is shaping up to post around 2,600 patents, up on 2012. All increases are due to increased overseas patents activity, with Irish patents falling. We shall see how December plays out, however.

Tuesday, October 1, 2013

1/10/2013: Irish Patenting Activity Q3 2013


Data on patents and patent applications for Ireland was published today by New Morning IP. Here's their summary and couple of my comments:

"In summary for September 2013:

  • 192 published applications or patents issued to Irish applicants through USPTO, EPO and PCT.
  • Top three assignees: Zamtec, Accenture Global Services and Digital Optics
  • Academic institutions accounted for 14% of Irish invention published this month
  • 41% of publications were Irish-originating inventions"
Now, my look at the data:
  • There was an increase from previous levels for Irish academic institutions share of all patents filed to 13.0%. In Q4 2012 - Q2 2013 these ranged between 7.9% and 10.7%.
  • In Q3 2013 there were total of 84 Irish academic patents granted or applied for, against the total number of Irish inventions at 274 and overseas inventions at 371. 
  • Numbers of Irish inventions in total declined from 283 in Q2 2013 to 274 in Q3 2013 and now stand at the lowest level since full quarterly records begin (Q4 2012).
  • Number of all patents applied for or granted rose to 645 in Q3 2013 from 636 in Q2 2013. This represents the second lowest level of activity for the entire period since Q4 2012.
Charts:


Wednesday, August 21, 2013

21/8/2013: Ireland's Potemkin Village (Knowledge) Economy

This is an unedited version of my Sunday Times article for August 18, 2013.


This week two news items offered significant implications for the framing of the budgetary policy direction for 2014-2015 and beyond.

First there was the revelation that the Revenue Commissioners are setting up a specialist unit to monitor the use of R&D tax credits by Irish and international firms. The second item was the publication of the Times Higher Education league tables ranking universities on their ability to attract corporate research funding. Both items are linked to the flagship of Irish economic policy that aims to establish R&D and innovation as the drivers of our future economic growth. Both touch upon our sacrosanct Potemkin village: the knowledge economy.


Since the Finance Act 2004, and throughout the crisis, governments have been keen on expanding Irish R&D activities amongst the indigenous enterprises and within the MNCs-dominated sectors. Over the last ten years, the main mechanism for doing so has been through the tax credits that allow the firms to claim R&D related spending. In Budgets 2012 and 2013, the current government significantly broadened the scope and the size of the scheme, and allowed new tax relief for key employees engaged in R&D activities.

Major consultancy firms providing supports for inward FDI, our state development agencies and business lobbyists – all have heralded these tax credits as visionary and imperative to making Ireland an attractive location for R&D.  Such framing of the policy debate makes this week’s news from the Revenue Commissioners significant. In truth, R&D tax credits are long overdue some serious scrutiny. The little evidence we do have suggests that the policy has failed to foster a pro-innovation culture in Irish economy after a decade long application of the scheme.

Firstly, tax credits-supported R&D activities remain too small to make any significant difference at the economy level. In 2004-2010 use of credits rose from EUR80 million to EUR225 million and at their peak, the credits amounted to less than one sixth of one percent of the Irish economy.

This is hardly a result of the scheme being too restrictive. In Ireland, firms are allowed to claim up to 25 percent of their R&D expenditure in credit. In the UK, the maximum is set at just 10 percent for the SMEs. The UK scheme is even more restrictive for larger enterprises. Furthermore, the UK applies strict criteria for SMEs that can qualify for such credits. Yet, UK R&D tax credits cover five times the share of GDP compared to Ireland.

Secondly, our tax credits scheme, along with the rest of the existent R&D and innovation support systems have failed to deliver any serious uplift in the R&D and innovation activities. Instead, these support systems have become a magnet for tax arbitrage by the multinationals and business cost optimization by Irish SMEs.

Take a look at the latest data on private sector R&D spend. Total R&D Expenditure by all enterprises in Ireland in 2012 stood at just EUR1.96 billion or 1.5 percent of our GNP. Between 2009 and 2012 this share of GNP has barely increased, rising only one percentage point, despite the large-scale increases in tax credits and other supports. The miracle of our 'knowledge economy' is, put frankly, quite feeble.

The achievements of 'Innovation Ireland' programmes are even less impressive when we consider what types of activities the R&D investments are being backed by tax credits. In 2007-2012 labour costs and current expenditures associated with R&D activities went up 29-31 percent, just as the economy was undergoing the alleged 'internal devaluation' normally associated with declines in these costs. In 2009-2012, costs associated with Payments for Licenses on Intellectual Property rose 357%. Total capital spending on R&D activities has fallen 30 percent over the same period. All in, CSO data shows that there might be significant cost shifting taking place via R&D tax credits being used to fund companies labour expenditures, as well as to optimise transfer pricing.


From economy's point of view, tax credits are one of the least efficient tools for stimulating investment in R&D and innovation. Research from the EU, published in February this year, examined the effectiveness of special tax allowances, tax credits and reduced income tax rates on R&D output. In assessing the quality of R&D projects, the authors looked at the R&D innovativeness and revenue potential. Using data on corporate patent applications to the European patent office, the authors found that a low tax rate on patent income is instrumental in attracting high quality innovative projects. In contrast, R&D tax credits and tax allowances were not found to have a significant impact on project quality.

International evidence shows that in general, all three forms of incentives are effective in raising the R&D activity. Ireland is one exception. Here, spending on R&D did not increase significantly in 2009-2012 period, rising in nominal terms by just EUR93 million for all companies and in real terms by 1.5 percent. The share of indigenous enterprises in total spending remained relatively stagnant at under 29 percent of total R&D spending. Total increase over 2009-2012 period in R&D spending by Irish-owned firms was only EUR14.5 million.

Tax credits are also reducing the overall transparency in the Irish economy when it comes to our firms performance and Government policies. Irish Government routinely references R&D tax credits as an example of pro-growth enterprise-focused policies. Yet there is no evidence directly linking economic growth, employment and enterprise outcomes to the tax credits.

In a welcome departure from our usual group-think, New Morning IP, the intellectual capital consultancy firm, recently published a report that argued that data shows no link between the introduction of the R&D tax credit and increased patenting activity by indigenous Irish companies. New Morning IP went on to state that “in our experience this tax credit has been used as a way of getting 'free money'…" It was a rare moment of truth in Ireland’s policy Byzantium, where interest groups routinely game the system for quick fixes, subsidies and protection, while ritualistically claiming unverified successes for such policies.

More distortions to the assessment of R&D tax credits effectiveness are induced by the fact that more than three quarters of R&D spend in Ireland is carried out by the MNCs. In some international studies, world-wide R&D investments by MNCs-based in Ireland are counted as if they take place here. One good example is the EU Industrial R&D Investment Scoreboard which ranked Ireland in top 10 EU countries for R&D investment in 2012. Per report, Ireland was host to 14 of the top-spending companies for R&D, but 11 of these were foreign companies and these accounted for 88.5 percent of all R&D spending attributed to Ireland.

In contrast to such reports, the European Patent Office data for 2012 put Ireland in 26th place in terms of total number of patent applications and in per-capita indigenous innovation terms, right between New Zealand and Cyprus. Not quite the achievement one finds promoted in Irish Government speeches and promotional brochures extoling the virtues of ‘Innovation Ireland’.


The above data on R&D investments and patenting activities in Ireland, correlates with the poor performance by the country academic institutions in attracting private sector research funding. The two problems are conjoined twins, born out of the lack of real innovation culture in Irish business.

This week's study by the Times Higher Education, ranked Ireland at the bottom of global league table in terms of private sector funding per academic researcher. Irish academics get an average of just over €6,000 from business research grants and general funds, or 12.5 times less than the world leader, South Korea. These numbers, of course, should be taken with a grain of salt. Lower rankings for Ireland, as well as for a number of other countries, can be in part explained by much broader academic research taking place in our universities, as well as in the bias in funding volumes in favour of specific technical disciplines. They are also reflective of the anti-innovation ethos of Ireland’s domestic enterprises. However, it also highlights the simple fact that Irish academics are often lacking policy and regulatory supports necessary to attract larger research grants.

The main point of all the data is that Irish policy supports for these high value-added activities are excessively focused on targeted tax incentives and are insufficiently aligned with the needs of the innovation-intensive sectors, businesses and entrepreneurs. Over-stimulation with targeted tax credits and exemptions is no substitute for the creation of a real culture of entrepreneurship and innovation.

To develop such culture, Ireland needs more flexible, more responsive public policy formation capable of supporting knowledge-intensive and rapidly evolving sectors, such as biotech, stem cells research, content-based ICT, remote medicine, human interface technology, customizable design and development technologies and so on. While we do have a benign corporate taxation regime, we also need a benign income tax regime to attract and anchor professional researchers and investors in innovation. Equally important are active state policies promoting start-ups and early stage enterprises. These require agile state systems for helping enterprises with issues relating to access to markets, IP, legal and regulatory matters and so on. Last, but not least, Ireland requires more streamlined and investor-friendly equity funding systems, tax laws and regulations and more open systems of IP and business ownership.



Box-out:

The latest report on the European construction industry, published this week by the German Ifo Institute shows that the residential construction sector in Europe will remain on course for further cutbacks with activity expected to hit a 20-years low in 2013-2014. The Institute forecasts show no pick up in residential building sector in Europe until 2015 and the market for new construction bottoming out at 45% below the level in 2006. The proverbial silver lining in the report comes in the Ifo forecasts for Ireland. Ifo experts see residential construction sector here switching to a 5.5% growth in 2014, followed by a 10% expansion in 2015. According to the report, “…it is encouraging that Ireland, which also had to overcome a major crisis in residential construction, is no longer a problem child.” Lets put these seemingly rosy forecasts into perspective. Currently, residential construction in Ireland is down 93 percent on peak year activity, marking the largest drop of any country in the EU. If the Ifo projections hold, by the end of 2015 Irish residential construction sector will be returned to the activity last seen in 2011. Not exactly encouraging, is it?